Brightsurf Science News & Current Events

May 17, 2000
Selected science students to perform simulated brain surgery at Cedars-Sinai's Maxine Dunitz Neurosurgical Institute
Seventh- and 8th-grade students at the third annual

85 percent of depressed patients improve when treated with both medication and psychotherapy, study finds
In a national study of 681 chronically depressed patients, psychotherapy combined with the antidepressant Serzone improved mood in 85 percent of patients after only three months of treatment.

The hair of the bear: USGS releases grizzly bear numbers in Glacier National Park
In a ground-breaking study that used DNA from bear hair to count bears, U.S.

Marshall Center's Fastrac engine team wins technology award
The team of engineers who designed and developed the new Fastrac rocket engine that will be used for the first powered flight of NASA's X-34 technology demonstrator is being honored for helping NASA achieve its goal of low-cost access to space.

Alzheimer's triggering enzyme identified
HHMI researchers have identified an enzyme that responds to toxic insults to brain cells and triggers neurodegeneration akin to that seen in people with Alzheimer's disease.

Daily sedative hiatus speeds recovery and cuts costs for ICU patients
By taking mechanically ventilated ICU patients off of sedatives briefly each day, University of Chicago researchers were able to reduce the duration of ventilation and ICU stays by one-third.

ORNL story tips May 2000
Lumberyards everywhere could revolutionize their businesses with a microwave pretreatment system that reduces from about two months to 10 days the amount of time needed to dry hardwoods.

Vaccine against melanoma proves successful for patients with disease spread
Jefferson Medical College researchers have found that a custom-made vaccine created from a patient's own cancer tumor cells appears effective in prolonging the survival of patients with malignant melanoma, the deadliest form of skin cancer.

Fast global satellite link tracks cars, monitors pipelines
A new satellite communication device can track a stolen car in near real time -- even before the owner finds out the car is gone.

Vion initiates Phase I continuous infusion trial of anticancer agent Triapine® At Albert Einstein College of Medicine / Montefiore Medical Center
Vion initiated an additional Phase I study of Triapine® to assess the safety and maximum tolerated dose when administered intravenously, by continuous infusion, over a 96-hour period at the Albert Einstein College of Medicine/Montefiore Medical Center, Bronx, New York, under the direction of Drs.

Research sheds new light on soot damage to artwork
Soot -- tiny pieces of black carbon emitted from trucks burning diesel fuel or factories burning coal -- accumulates on paintings, causing the image to darken over time.

Jefferson scientists' results raise hopes for ovarian cancer vaccine
Jefferson Medical College researchers are getting some positive results in early testing of an ovarian cancer vaccine made from a patient's own cancer cells.

American Thoracic Society Journal news tips for May 2000
The following news tips are from studies published in the American Thoracic Society journals for May: 1.

Web medicine: The new 'apple a day'?
The Internet has the potential to dramatically affect the way medicine is practiced in this country, but surfing the Web is not going to replace a visit to the doctor's office any time soon.

SmithKline Beecham's landmark Parkinson's disease study provides new hope for patients
Early treatment with ReQuip® (ropinirole hydrochloride), SmithKline Beecham's new drug for Parkinson's disease, significantly reduces the risk of levodopa (L-dopa)-induced dyskinesia according to the multinational landmark 5-year study published today in the New England Journal of Medicine.

Rare medieval medical books and manuscripts on display
A 12th century Latin manuscript,

AAAS looks at 50 years of science journalism
A new booklet published by AAAS looks at 50 years of science journalism, focusing on the theme of communicating science to the public and the challenges faced by journalists reporting on science.

Drug-psychotherapy combo found highly effective in depression study
The prescription drug Serzone, combined with psychotherapy designed specifically for chronic depression, produced an 85- percent response rate among 681 patients under treatment for chronic forms of major depression.

Jefferson scientists find molecular markers to predict prostate cancer relapse
Cancer researchers at Jefferson Medical College have found two potential molecular biomarkers that may predict the effectiveness of therapy for prostate cancer and the potential for relapse following radiation therapy.

Chemotherapy and radiation at the same time may help lung cancer patients live longer
Giving advanced lung cancer patients a common chemotherapy drug at the same time they receive daily radiation may help them live longer than by taking one treatment at a time.

Shedding light on luminescence: Scientists visualize structure of the photoprotein aequorin
In this week's issue of the journal Nature, Shimomura and his colleagues James Head from Boston University, Katsunori Teranishi from Mei University (Japan), and Satoshi Inouye from Chisso Corporation (Japan), describe the three- dimensional crystal structure of aequorin, the photoprotein that illuminates jellyfish, centophores and many other luminescing organisms.

By all measurements -- Indiana's forests are growing
The report card is in and the news is very good.
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.